C. Gury
- Neurology top 5%
- Neurological disorders and treatments 2
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment 9
- Electroconvulsive Therapy Studies 3
- Bipolar Disorder and Treatment 3
- Epilepsy research and treatment 3
-
- Cardiac electrophysiology and arrhythmias 4
- Blood Pressure and Hypertension Studies 2
-
- Diet and metabolism studies 2
C. Gury
22 papers receiving 542 citations
Peers
Comparison fields: 5 of 69
- Neurology 229
- Psychiatry and Mental health 179
- Cellular and Molecular Neuroscience 132
- Biological Psychiatry 16
- Anesthesiology and Pain Medicine 24
Countries citing papers authored by C. Gury
This map shows the geographic impact of C. Gury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Gury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Gury more than expected).
Fields of papers citing papers by C. Gury
This network shows the impact of papers produced by C. Gury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Gury. The network helps show where C. Gury may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Gury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 3 | |
| 2 | 2007 | 5 | |
| 3 | 2006 | 14 | |
| 4 | 2006 | 25 | |
| 5 | 2006 | 15 | |
| 6 | 2006 | 83 | |
| 7 | 2005 | 11 | |
| 8 | 2005 | 1 | |
| 9 | 2004 | 109 | |
| 10 | 2004 | 5 | |
| 11 | 2004 | 12 | |
| 12 | 2004 | 1 | |
| 13 | Pharmacologie et toxicologie cliniques de l'ecstasy | 2003 | 1 |
| 14 | Comment minimiser les risques associés à un allongement significatif de l’intervalle QTc chez les personnes souffrant de schizophrénie.Recommandations consensuelles du Cardiac safety in schizophrenia group | 2003 | 1 |
| 15 | Risk of QT prolongated and torsade de pointes induced by antipsychotics | 2002 | 1 |
| 16 | 2002 | 194 | |
| 17 | [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia]. | 2001 | 47 |
| 18 | Phase IV clinical trial setting : efficacy study of midodrine in orthostatic hypotension induced by psychotropic drugs | 2001 | 1 |
| 19 | [Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability]. | 2000 | 18 |
| 20 | [Leponex: experience of the hospital pharmacist]. | 1995 | 2 |
About C. Gury
C. Gury is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology, Toxicology, Cardiology and Cardiovascular Medicine and Developmental Neuroscience, having authored 23 papers that have together received 592 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (9 papers), Cardiac electrophysiology and arrhythmias (4 papers), Electroconvulsive Therapy Studies (3 papers), Bipolar Disorder and Treatment (3 papers), Epilepsy research and treatment (3 papers), Neurological disorders and treatments (2 papers), Diet and metabolism studies (2 papers) and Blood Pressure and Hypertension Studies (2 papers). The work is most often cited by research in Neurology (229 citations), Psychiatry and Mental health (179 citations), Cellular and Molecular Neuroscience (132 citations), Biological Psychiatry (16 citations) and Anesthesiology and Pain Medicine (24 citations). C. Gury has collaborated with scholars based in France, Australia and Canada. Frequent co-authors include Jean‐Louis Mas, Danièle Ranoux, J Fondarai, Mathieu Zuber, François‐Xavier Roux, Philippe Page, F. Nataf, P. Iaria, Sylvie Lancrenon and Élie Hantouche. Their work appears in journals such as L Encéphale, European Neuropsychopharmacology, Pharmacoepidemiology and Drug Safety, Neurosurgery and Journal of Affective Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.